These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22530561)

  • 21. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA; Soliman II; Louis D
    Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
    Kulkarni AS; Gaja JB
    PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.
    Adibkia K; Shokri J; Barzegar-Jalali M; Solduzian M; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2014 Jan; 113():10-4. PubMed ID: 24060925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of physicochemical properties of piroxicam liquisolid compacts.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Pharm Dev Technol; 2007; 12(3):337-43. PubMed ID: 17613897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution enhancement of tadalafil by liquisolid technique.
    Lu M; Xing H; Yang T; Yu J; Yang Z; Sun Y; Ding P
    Pharm Dev Technol; 2017 Feb; 22(1):77-89. PubMed ID: 27268461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquisolid systems and aspects influencing their research and development.
    Vraníková B; Gajdziok J
    Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
    Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
    Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Ceolus KG-802 on the dissolution rate of fenofibrate liquisolid tablets: Preformulation and formulation development studies.
    Karmarkar AB
    Drug Discov Ther; 2010 Dec; 4(6):493-8. PubMed ID: 22491315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enhancing of drug bioavailability using liquisolid system formulation].
    Gajdziok J; Vraníková B
    Ceska Slov Farm; 2015 Jun; 64(3):55-66. PubMed ID: 26400228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
    Kapure VJ; Pande VV; Deshmukh PK
    J Pharm (Cairo); 2013; 2013():315902. PubMed ID: 26555972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin.
    Taupitz T; Dressman JB; Klein S
    Eur J Pharm Biopharm; 2013 May; 84(1):208-18. PubMed ID: 23246797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
    Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
    J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
    Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
    Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.